QGEN Stock Analysis: Buy, Sell, or Hold?
QGEN - QIAGEN N.V.
$53.67
-0.04 (-0.07%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 04, 2026
3d
Get Alerted When QGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: QGEN is fairly valued with market pricing in 3.1% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: QGEN is fairly valued with market pricing in 3.1% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$63.55
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$39.46
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: QGEN is currently trading at $53.67, which is considered extended relative to its 30-day fair value range of $45.39 to $53.13. The stock's valuation (Forward PE: 20.3) is in line with its historical norms (18.5). At these levels, the market is pricing in 3.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, QGEN is in a uptrend. Immediate support is located at $46.07, while resistance sits at $57.81.
Market Sentiment: QGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, QGEN is in a uptrend. Immediate support is located at $46.07, while resistance sits at $57.81.
Market Sentiment: QGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$45.39 -
$53.13
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding QGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.32)
- NEUTRAL: Market pricing in 3.1% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$45.39 -
$53.13
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$46.07
Resistance Level
$57.82
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
20.28
Wall Street Target
$53.32
(-0.7%)
Revenue Growth (YoY)
6.1%
Earnings Growth (YoY)
32.5%
Profit Margin
19.6%
Valuation Premium vs History
+3.1% premium
PE vs Historical
20.3 vs 18.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.1%
(market-implied from PE analysis)
1-Year Target
$55.38
(+3%)
2-Year Target
$57.09
(+6%)
3-Year Target
$58.86
(+10%)
3-Yr Target (if PE normalizes)
(PE: 20→19)
PE COMPRESSION
$53.68
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 6.7%)
$71.79
(+34%)
Base:
(SPY PE: 20.3, Growth: 6.7%)
$65.30
(+22%)
Bear:
(PE: 17.2, Growth: 6.7%)
$55.51
(+3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 27.69 | Current EPS (TTM): $1.95
Bull Case
$80.64
(+50%)
Analyst growth 35.8%, PE expands to 30.5
Base Case
$73.31
(+37%)
Market implied 35.8%, PE stable at 27.7
Bear Case
$36.71
(-32%)
Severe decline -20.0%, PE contracts to 23.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 12:03 AM ET
Data refreshes hourly during market hours. Next update: 1:03 AM
Data refreshes hourly during market hours. Next update: 1:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced QGEN Option Strategies
Professional options setups generated by AI based on today's QGEN price and gamma walls.
